Reassortment of Bunyavirus in ticks and animal models
- Institution
- CLEVELAND CLINIC LERNER COM-CWRU, OH
- Principal investigator
- Jae U Jung
- Funding
- $578K
- Duration
- 2022–2027
Moonbase score
Still being scored
Abstract
Project Summary/Abstract Listed in the WHO top nine most dangerous pathogens, SFTSV has 12-30% fatality rates, rapidly spreads through tick-to-animal/human, human-to-human and animal-to-human and induces immunopathogenic disease with a characteristic thrombocytopenia. Virus reassortment is a process of genetic recombination that is exclusive to segmented RNA viruses in which co-infection of a cell of natural host and vector with multiple viruses may result in the shuffling of gene segments to generate progeny viruses with novel genome combinations. Reassortment greatly affects virus fitness and directly influences antigenic variation, confounding available methods of virus control. In this application, we will test the hypothesis that tick-mediated natural course of SFTSV infection and reassortment introduces phenotypic changes of fitness, transmissibility, antigenicity, or pathogenicity into progeny reassortants. The goal of this study is to demonstrate the natural course of SFTSV infection and reassortment for fitness, immunogenicity, transmissibility, and pathogenesis in in vitro and in vivo animal models and H. longicornis ticks, ultimately bridging basic research to clinical application.
LOADING MOONBASE SCORE
Questions for CLEVELAND CLINIC LERNER COM-CWRU
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Cleveland Clinic Lerner Com-CwruNot yet scored
KSHV-mediated metabolic reprogramming for LANA expression and viral persistency
Jae U Jung · $675K · 2024–2029
- NIH · Cleveland Clinic Lerner Com-CwruNot yet scored
Development of three KSHV vaccine platforms and chimeric MHV68-K-G for in vivo mouse infection study
Jae U Jung · $972K · 2024–2029
- NIH · Cleveland Clinic Lerner Com-Cwru66
Immune cell activation and associated blood brain barrier changes across different stages of Alzheimer's disease
Jagan Ayyappan Pillai · $738K · 2022–2028